BERNSTEIN HAROLD (President, R&D & CMO) sold 14.85K shares of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $381.1K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/3/2026ACC: 0002050172-26-000023
Officer· President, R&D & CMO
Since Mar 2026
-14.85K
Net shares
Net seller
$381.1K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
14.85K acquired · 29.71K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+14.85K
Price / share
$10.42
Trade value
$154.77K
% of position
New position
6/1/2026
0.00→14.85K
Common Stock
Direct
Shares
−13.25K
Price / share
$25.57
Trade value
$338.94K
% of position
89.2%
6/1/2026
14.85K→1.60K
Common Stock
Direct
Shares
−1.60K
Price / share
$26.36
Trade value
$42.17K
% of position
New position
6/1/2026
1.60K→0.00
Total
Net shares
+0.00
Net value
-$226.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +14.85K | $10.42 | $154.77K | New position | 0.00 | 14.85K |
| Common Stock Direct | 6/1/2026 | S · Sale | −13.25K | $25.57 | $338.94K | 89.2% | 14.85K | 1.60K |
| Common Stock Direct | 6/1/2026 | S · Sale | −1.60K | $26.36 | $42.17K | New position | 1.60K | 0.00 |
| Total | +0.00 | -$226.34K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
14.85K shares
Shares
−14.85K
Strike price
10.42
Held after
207.55K
Exercisable
—
6/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock14.85K shares | 6/1/2026 | M · Option Exercise | −14.85K | 10.42 | — | 207.55K |